{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:18:18Z","timestamp":1793161098592,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To investigate the differences in clinical and genetic characteristics between males and females with central serous chorioretinopathy (CSC). Consecutive 302 patients (mean age; 56.3\u2009\u00b1\u200911.7, male\/female: 249\/53) with CSC were evaluated on the initial presentation. All CSC patients underwent fluorescein angiography and indocyanine green angiography (FA\/ICGA), swept-source or spectral-domain optical coherence tomography (OCT), and fundus autofluorescence (FAF) to confirm a diagnosis. All patients were genotyped for rs800292 and rs1329428 variants of <jats:italic>CFH<\/jats:italic> using TaqMan technology. On the initial presentation, female patients were significantly older (p\u2009=\u20092.1\u2009\u00d7\u200910<jats:sup>\u20134<\/jats:sup>, female 61.6\u2009\u00b1\u200912.4 vs male 55.1\u2009\u00b1\u200911.3) and had thinner subfoveal choroidal thickness (p\u2009=\u20093.8\u2009\u00d7\u200910<jats:sup>\u20135<\/jats:sup>) and higher central retinal thickness (p\u2009=\u20093.0\u2009\u00d7\u200910<jats:sup>\u20133<\/jats:sup>) compared to males. A descending tract was more frequently seen in males than in females (p\u2009=\u20098.0\u2009\u00d7\u200910<jats:sup>\u20134<\/jats:sup>, 18.1% vs 0%). Other clinical characteristics were comparable between the sexes. The risk allele frequency of both variants including <jats:italic>CFH<\/jats:italic> rs800292 and <jats:italic>CFH<\/jats:italic> rs1329428 was comparable between males and females (<jats:italic>CFH<\/jats:italic> rs800292 A allele male 51.2% vs female 47.2%, <jats:italic>CFH<\/jats:italic> rs1329428 T allele male 56.2% vs 52.8%). On the initial presentation, age, subfoveal choroidal thickness and central retinal thickness differ between males and females in eyes with CSC. A descending tract may be a strong male finding in CSC.<\/jats:p>","DOI":"10.1038\/s41598-022-14777-8","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T15:20:39Z","timestamp":1655911239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Distinct characteristics of central serous chorioretinopathy according to gender"],"prefix":"10.1038","volume":"12","author":[{"given":"Seigo","family":"Yoneyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Sakurada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Terao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiyo","family":"Shijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuki","family":"Kusada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Kikushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Mabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Sotozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,22]]},"reference":[{"key":"14777_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","volume":"48","author":"A Daruich","year":"2015","unstructured":"Daruich, A. et al. Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis. Prog. Retin Eye Res. 48, 82\u2013118. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.05.003 (2015).","journal-title":"Prog. Retin Eye Res."},{"key":"14777_CR2","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","volume":"126","author":"S Mrejen","year":"2019","unstructured":"Mrejen, S. et al. Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy. Ophthalmology 126, 576\u2013588. https:\/\/doi.org\/10.1016\/j.ophtha.2018.12.048 (2019).","journal-title":"Ophthalmology"},{"key":"14777_CR3","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.ophtha.2013.11.020","volume":"121","author":"A Miki","year":"2014","unstructured":"Miki, A. et al. Common variants in the complement factor H gene confer genetic susceptibility to central serous chorioretinopathy. Ophthalmology 121, 1067\u20131072. https:\/\/doi.org\/10.1016\/j.ophtha.2013.11.020 (2014).","journal-title":"Ophthalmology"},{"key":"14777_CR4","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1167\/iovs.18-25497","volume":"59","author":"A Miki","year":"2018","unstructured":"Miki, A. et al. Genome-wide association study to identify a new susceptibility locus for central serous chorioretinopathy in the Japanese population. Investig. Ophthalmol. Vis. Sci. 59, 5542\u20135547. https:\/\/doi.org\/10.1167\/iovs.18-25497 (2018).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"14777_CR5","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s42003-019-0712-z","volume":"2","author":"Y Hosoda","year":"2019","unstructured":"Hosoda, Y. et al. Genome-wide association analyses identify two susceptibility loci for pachychoroid disease central serous chorioretinopathy. Commun. Biol. 2, 468. https:\/\/doi.org\/10.1038\/s42003-019-0712-z (2019).","journal-title":"Commun. Biol."},{"key":"14777_CR6","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/humu.22551","volume":"35","author":"C Schubert","year":"2014","unstructured":"Schubert, C. et al. Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathy. Hum. Mutat. 35, 859\u2013867. https:\/\/doi.org\/10.1002\/humu.22551 (2014).","journal-title":"Hum. Mutat."},{"key":"14777_CR7","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1001\/jamaophthalmol.2018.3190","volume":"136","author":"RL Schellevis","year":"2018","unstructured":"Schellevis, R. L. et al. Role of the complement system in chronic central serous chorioretinopathy: A genome-wide association study. JAMA Ophthalmol. 136, 1128\u20131136. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.3190 (2018).","journal-title":"JAMA Ophthalmol."},{"key":"14777_CR8","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.1073\/pnas.1802212115","volume":"115","author":"Y Hosoda","year":"2018","unstructured":"Hosoda, Y. et al. CFH and VIPR2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy. Proc. Natl. Acad. Sci. USA 115, 6261\u20136266. https:\/\/doi.org\/10.1073\/pnas.1802212115 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"14777_CR9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ajo.2008.05.032","volume":"146","author":"RF Spaide","year":"2008","unstructured":"Spaide, R. F., Koizumi, H. & Pozzoni, M. C. Enhanced depth imaging spectral-domain optical coherence tomography. Am. J. Ophthalmol. 146, 496\u2013500. https:\/\/doi.org\/10.1016\/j.ajo.2008.05.032 (2008).","journal-title":"Am. J. Ophthalmol."},{"key":"14777_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41433-018-0158-4","volume":"33","author":"CMG Cheung","year":"2019","unstructured":"Cheung, C. M. G. et al. Pachychoroid disease. Eye 33, 14\u201333. https:\/\/doi.org\/10.1038\/s41433-018-0158-4 (2019).","journal-title":"Eye"},{"key":"14777_CR11","first-page":"605","volume":"69","author":"AE Maumenee","year":"1965","unstructured":"Maumenee, A. E. Macular diseases: Clinical manifestations. Trans. Am. Acad. Ophthalmol. Otolaryngol. 69, 605\u2013613 (1965).","journal-title":"Trans. Am. Acad. Ophthalmol. Otolaryngol."},{"key":"14777_CR12","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1167\/iovs.11-7729","volume":"52","author":"M Hirata","year":"2011","unstructured":"Hirata, M. et al. Macular choroidal thickness and volume in normal subjects measured by swept-source optical coherence tomography. Investig. Ophthalmol. Vis. Sci. 52, 4971\u20134978. https:\/\/doi.org\/10.1167\/iovs.11-7729 (2011).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"14777_CR13","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41433-018-0163-7","volume":"32","author":"D Hanumunthadu","year":"2018","unstructured":"Hanumunthadu, D. et al. Gender variation in central serous chorioretinopathy. Eye 32, 1703\u20131709. https:\/\/doi.org\/10.1038\/s41433-018-0163-7 (2018).","journal-title":"Eye"},{"key":"14777_CR14","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1136\/bjophthalmol-2018-312431","volume":"103","author":"MG Ersoz","year":"2019","unstructured":"Ersoz, M. G., Arf, S., Hocaoglu, M., SaymanMuslubas, I. & Karacorlu, M. Patient characteristics and risk factors for central serous chorioretinopathy: An analysis of 811 patients. Br. J. Ophthalmol. 103, 725\u2013729. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312431 (2019).","journal-title":"Br. J. Ophthalmol."},{"key":"14777_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1136\/bjo.2006.098277","volume":"91","author":"MC Grieshaber","year":"2007","unstructured":"Grieshaber, M. C., Staub, J. J. & Flammer, J. The potential role of testosterone in central serous chorioretinopathy. Br. J. Ophthalmol. 91, 118\u2013119. https:\/\/doi.org\/10.1136\/bjo.2006.098277 (2007).","journal-title":"Br. J. Ophthalmol."},{"key":"14777_CR16","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1097\/IAE.0000000000000198","volume":"34","author":"E Nudleman","year":"2014","unstructured":"Nudleman, E., Witmer, M. T., Kiss, S., Williams, G. A. & Wolfe, J. D. Central serous chorioretinopathy in patients receiving exogenous testosterone therapy. Retina 34, 2128\u20132132. https:\/\/doi.org\/10.1097\/IAE.0000000000000198 (2014).","journal-title":"Retina"},{"key":"14777_CR17","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00417-018-3985-x","volume":"256","author":"E Ciloglu","year":"2018","unstructured":"Ciloglu, E., Unal, F. & Dogan, N. C. The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels. Graefes Arch. Clin. Exp. Ophthalmol. 256, 1111\u20131116. https:\/\/doi.org\/10.1007\/s00417-018-3985-x (2018).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"14777_CR18","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.ophtha.2010.08.017","volume":"118","author":"Y Imamura","year":"2011","unstructured":"Imamura, Y., Fujiwara, T. & Spaide, R. F. Fundus autofluorescence and visual acuity in central serous chorioretinopathy. Ophthalmology 118, 700\u2013705. https:\/\/doi.org\/10.1016\/j.ophtha.2010.08.017 (2011).","journal-title":"Ophthalmology"},{"key":"14777_CR19","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.oret.2020.07.026","volume":"4","author":"J Chhablani","year":"2020","unstructured":"Chhablani, J., Cohen, F. B., Central Serous Chorioretinopathy International, G. Multimodal imaging-based central serous chorioretinopathy classification. Ophthalmol. Retina 4, 1043\u20131046. https:\/\/doi.org\/10.1016\/j.oret.2020.07.026 (2020).","journal-title":"Ophthalmol. Retina"},{"key":"14777_CR20","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/eye.2016.113","volume":"30","author":"WJ Lee","year":"2016","unstructured":"Lee, W. J., Lee, J. H. & Lee, B. R. Fundus autofluorescence imaging patterns in central serous chorioretinopathy according to chronicity. Eye 30, 1336\u20131342. https:\/\/doi.org\/10.1038\/eye.2016.113 (2016).","journal-title":"Eye"},{"key":"14777_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.oret.2020.07.011","volume":"5","author":"N Imanaga","year":"2021","unstructured":"Imanaga, N. et al. Scleral thickness in central serous chorioretinopathy. Ophthalmol. Retina 5, 285\u2013291. https:\/\/doi.org\/10.1016\/j.oret.2020.07.011 (2021).","journal-title":"Ophthalmol. Retina"},{"key":"14777_CR22","doi-asserted-by":"publisher","first-page":"11906","DOI":"10.1038\/s41598-019-48494-6","volume":"9","author":"Y Fukuda","year":"2019","unstructured":"Fukuda, Y. et al. Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration. Sci. Rep. 9, 11906. https:\/\/doi.org\/10.1038\/s41598-019-48494-6 (2019).","journal-title":"Sci. Rep."},{"key":"14777_CR23","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1097\/IAE.0000000000000964","volume":"36","author":"S Yoneyama","year":"2016","unstructured":"Yoneyama, S. et al. Genetic factors associated with choroidal vascular hyperpermeability and subfoveal choroidal thickness in polypoidal choroidal vasculopathy. Retina 36, 1535\u20131541. https:\/\/doi.org\/10.1097\/IAE.0000000000000964 (2016).","journal-title":"Retina"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14777-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14777-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14777-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:47:14Z","timestamp":1669355234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14777-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,22]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["14777"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-14777-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,22]]},"assertion":[{"value":"17 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10565"}}